NO981502L - 4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo£3,4':4,5|furo(3,2-b)pyridin-6,8£7H|-dionderivater for bekjempelse av endoparasitter og fremgangsmÕte for fremstilling av nevnte derivater - Google Patents

4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo£3,4':4,5|furo(3,2-b)pyridin-6,8£7H|-dionderivater for bekjempelse av endoparasitter og fremgangsmÕte for fremstilling av nevnte derivater

Info

Publication number
NO981502L
NO981502L NO981502A NO981502A NO981502L NO 981502 L NO981502 L NO 981502L NO 981502 A NO981502 A NO 981502A NO 981502 A NO981502 A NO 981502A NO 981502 L NO981502 L NO 981502L
Authority
NO
Norway
Prior art keywords
derivatives
furo
pyrrolo
tetrahydro
pyridine
Prior art date
Application number
NO981502A
Other languages
English (en)
Other versions
NO323609B1 (no
NO981502D0 (no
Inventor
Peter Jeschke
Achim Harder
Norbert Mencke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO981502L publication Critical patent/NO981502L/no
Publication of NO981502D0 publication Critical patent/NO981502D0/no
Publication of NO323609B1 publication Critical patent/NO323609B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO19981502A 1995-10-19 1998-04-02 4a,5a,8a,8b-tetrahydro-6H-pyrrolo[3,4':4,5]furo(3,2-b)pyridin-6,8[7H]-dionderivater, anvendelse derav samt fremgangsmate for fremstilling derav, 1,2,3,4,4a,5a,8a,8b-oktahydro-6H-pyrrolo[3',4':4,5]furo[3,2-b]pyridin-6,8(7H)-dion og 1,2,4a,5a,8a,8b-heksahydro-6H-pyrrolo[3',4':4,5]furo[3,2-b]pyridin-6,8(7H)-dionderivater, fremgangsmate for fremstilling derav, endoparasiticidmidler samt fremgangsmate for fremstilling av disse. NO323609B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19538960A DE19538960A1 (de) 1995-10-19 1995-10-19 4a,5a,8a,8b-Tetrahydro-6H-pyrrolo [3',4':4,5] furo [3,2-b] pyridin-6,8(7H)-dion Derivate zur Bekämpfung von Endoparasiten, Verfahren zu ihrer Herstellung
PCT/EP1996/004346 WO1997014695A1 (de) 1995-10-19 1996-10-07 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO[3',4':4,5]FURO [3,2-b]PYRIDIN-6,8(7H)-DION DERIVATE ZUR BEKÄMPFUNG VON ENDOPARASITEN UND VERFAHREN ZU IHRER HERSTELLUNG

Publications (3)

Publication Number Publication Date
NO981502L true NO981502L (no) 1998-04-02
NO981502D0 NO981502D0 (no) 1998-04-02
NO323609B1 NO323609B1 (no) 2007-06-18

Family

ID=7775277

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981502A NO323609B1 (no) 1995-10-19 1998-04-02 4a,5a,8a,8b-tetrahydro-6H-pyrrolo[3,4':4,5]furo(3,2-b)pyridin-6,8[7H]-dionderivater, anvendelse derav samt fremgangsmate for fremstilling derav, 1,2,3,4,4a,5a,8a,8b-oktahydro-6H-pyrrolo[3',4':4,5]furo[3,2-b]pyridin-6,8(7H)-dion og 1,2,4a,5a,8a,8b-heksahydro-6H-pyrrolo[3',4':4,5]furo[3,2-b]pyridin-6,8(7H)-dionderivater, fremgangsmate for fremstilling derav, endoparasiticidmidler samt fremgangsmate for fremstilling av disse.

Country Status (23)

Country Link
US (2) US6110928A (no)
EP (1) EP0871630B1 (no)
JP (1) JP4157163B2 (no)
KR (1) KR100444144B1 (no)
CN (1) CN1111535C (no)
AR (1) AR004023A1 (no)
AT (1) ATE211475T1 (no)
AU (1) AU706836B2 (no)
BR (1) BR9611002B1 (no)
CZ (1) CZ295075B6 (no)
DE (2) DE19538960A1 (no)
DK (1) DK0871630T3 (no)
ES (1) ES2170271T3 (no)
HU (1) HUP9802854A3 (no)
NO (1) NO323609B1 (no)
NZ (1) NZ320174A (no)
PL (1) PL185960B1 (no)
PT (1) PT871630E (no)
SK (1) SK284914B6 (no)
TR (1) TR199800686T2 (no)
TW (1) TW466241B (no)
WO (1) WO1997014695A1 (no)
ZA (1) ZA968788B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19719839A1 (de) * 1997-05-12 1998-11-19 Bayer Ag 6-Substituierte 1,2,4a,5a,8a,8b-Hexahydro- und 1,2,3,4,4a,5a,8a,8b-Oktahydro-6H-pyrrolo/3',4':4,5/furo/3,2-b/pyrid-8(7H)-on Derivate und ihre Verwendung zur Bekämpfung von Endoparasiten
DE10201544A1 (de) * 2002-01-17 2003-07-31 Bayer Cropscience Ag Substituierte Pyrazoline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4032090A1 (de) * 1990-02-13 1991-08-14 Bayer Ag Polycyclische 3-aryl-pyrrolidin-2,4-dion-derivate
DE4121365A1 (de) * 1991-06-28 1993-01-14 Bayer Ag Substituierte 1-h-3-aryl-pyrrolidin-2,4-dion-derivate

Also Published As

Publication number Publication date
AR004023A1 (es) 1998-09-30
PT871630E (pt) 2002-06-28
DE19538960A1 (de) 1997-04-24
JPH11513675A (ja) 1999-11-24
DE59608617D1 (de) 2002-02-28
AU7286596A (en) 1997-05-07
DK0871630T3 (da) 2002-04-29
PL185960B1 (pl) 2003-09-30
AU706836B2 (en) 1999-06-24
HUP9802854A2 (hu) 1999-05-28
BR9611002B1 (pt) 2010-11-30
SK284914B6 (sk) 2006-02-02
KR19990063812A (ko) 1999-07-26
TW466241B (en) 2001-12-01
US6291472B1 (en) 2001-09-18
SK49298A3 (en) 1998-09-09
CN1111535C (zh) 2003-06-18
CN1204335A (zh) 1999-01-06
PL326323A1 (en) 1998-09-14
EP0871630A1 (de) 1998-10-21
BR9611002A (pt) 1999-07-13
ZA968788B (en) 1996-12-03
KR100444144B1 (ko) 2005-01-13
NO323609B1 (no) 2007-06-18
US6110928A (en) 2000-08-29
CZ118898A3 (cs) 1998-08-12
WO1997014695A1 (de) 1997-04-24
TR199800686T2 (xx) 1998-07-21
EP0871630B1 (de) 2002-01-02
HK1017359A1 (en) 1999-11-19
CZ295075B6 (cs) 2005-05-18
NZ320174A (en) 2000-12-22
NO981502D0 (no) 1998-04-02
ES2170271T3 (es) 2002-08-01
ATE211475T1 (de) 2002-01-15
JP4157163B2 (ja) 2008-09-24
HUP9802854A3 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
DK0733635T3 (da) Krystalformer af et thieno[2,3-b] [1,5]benzodiazepin-derivat og fremgangsmåde til deres fremstilling
HUP9700885A3 (en) Novel process for producing thieno[3,2-c]pyridine derivatives
NZ304095A (en) 9-(substituted acylamino) tetracyclic derivatives and medicaments
AU6612096A (en) Benzo{g}quinoline derivatives
AU570256B2 (en) Imidazopyrrolopyridines/quinolines and (3,2-b) pyridofused thieno/furo derivatives thereof
PL332382A1 (en) Derivatives of 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine
AU3611093A (en) Substituted furo(3',4':6,7)indolizino(1,2-b)quinolinones
DK0733634T3 (da) Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat
AU5154699A (en) 4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives
AU1277092A (en) Tetrahydrothieno(2,3-c)pyridine derivatives, process for their preparation and their pharmaceutical application
AU3395293A (en) 1,4-dioxino(2,3-b)pyridine derivatives
NO981502L (no) 4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo£3,4':4,5|furo(3,2-b)pyridin-6,8£7H|-dionderivater for bekjempelse av endoparasitter og fremgangsmÕte for fremstilling av nevnte derivater
EP0505510A4 (en) Antipsychotic hexahydro-2-i(h)-indeno 1,2-c)pyridine derivatives
HUP9602054A2 (en) Benzofuro- and benzothieno[3,2-b]pyridine derivatives, pharmaceutical compositions containing them, and process for the preparation thereof
NZ326039A (en) Process for making 3,4-dihydro-pyrimidin-2(1h)-one derivatives
PL324928A1 (en) Derivatives of pyrimidin-4-one, their application, intermediate compounds for their production and methods of obtaining such intermediate compounds
HUP0003046A3 (en) Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
GB8907480D0 (en) Separation of insomers of furo(3,4-c)pyridine derivatives
HUP0002380A3 (en) 6-substituted 1,2,4a,5a,8a,8b-hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6h-pyrrolo-[3',4':4,5]furo[3,2-b]pyrid-8(7h)-on derivatives, their use, pharmaceutical compositions containing them and process for their preparation
PL326179A1 (en) Derivatives of 2,3-dihydrofuro(2,3-b)pyridine, 3,4-dihydro-2h-pyrane(2,3-b)pyridine and benzo(b)furo(2,3-b)pyrazine
HK1030934A (en) Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase
ZA932721B (en) Substituted Indolizino[1,2-b]quinolinones
BR9605440A (pt) Aminometil-2,3,8,9-tetrahidro.7h.1,4-dioxino (2,3-e)-indol-8-onas e derivados
SI1023063T1 (en) INDENO(1,2-c), NAPHTHO(1,2-c)- AND BENZO(6,7)CYCLOHEPTA(1,2-c)PYRAZOLE DERIVATIVES
SI0839136T1 (en) BENZO(g)QUINOLINE DERIVATIVES

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees